Provecs Medical Overview

  • Founded
  • 2005
  • Status
  • Out of Business
  • Employees
  • 4
  • Latest Deal Type
  • Out of Business

Provecs Medical General Information


Developer of a proprietary enviro adenoviral platform intended to provide novel treatment options for patients with advanced cancers and infectious diseases. The company's platform leverages technology to develop a versatile and cost-effective platform that locally delivers bio-molecules known to be non-tolerable in systemic use or impossible to manufacture, such as membrane proteins, short-lived cytokines, enabling clients to get access to tumor gene therapy to expose the tumor to the immune system.

Contact Information

Ownership Status
Out of Business
Financing Status
Formerly VC-backed
Primary Industry
Other Industries
Drug Discovery
Primary Office
  • Martinistraße 64
  • 20251 Hamburg
  • Germany
+49 040 000000000
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Provecs Medical Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
4. Out of Business 01-Aug-2020 Completed Out of Business
3. Secondary Transaction - Private 28-Jul-2015 Completed Generating Revenue
2. Angel (individual) 01-Jan-2010 Completed Startup
1. Seed Round 03-Aug-2007 Completed Startup
To view Provecs Medical’s complete valuation and funding history, request access »

Provecs Medical Signals

Growth Rate

0.80% Weekly
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers


Similarweb Unique Visitors


Majestic Referring Domains


PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial